Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Targeted drug conjugates: principles and progress.

M C Garnett1

  • 1School of Pharmaceutical Sciences, University of Nottingham, University Park, Nottingham NG7 2RD, UK. martin.garnett@nottingham.ac.uk

Advanced Drug Delivery Reviews
|December 4, 2001
PubMed
Summary

Antibody-drug conjugates (ADCs) represent a significant advancement in cancer treatment. Recent clinical successes demonstrate the effectiveness and selectivity of these targeted therapies, potentially ushering in a new era for chemotherapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Developing novel anthelmintics: the stability of cysteine proteinase activity in a supernatant extract of papaya latex.

Heliyon·2021
Same author

Multiscale modeling of drug-polymer nanoparticle assembly identifies parameters influencing drug encapsulation efficiency.

Journal of chemical theory and computation·2015
Same author

The relative anthelmintic efficacy of plant-derived cysteine proteinases on intestinal nematodes.

Journal of helminthology·2013
Same author

The anthelmintic efficacy of papaya latex in a rodent-nematode model is not dependent on fasting before treatment.

Journal of helminthology·2011
Same author

Evaluation of poly (glycerol-adipate) nanoparticle uptake in an in vitro 3-D brain tumor co-culture model.

Experimental biology and medicine (Maywood, N.J.)·2007
Same author

Uptake and metabolism of novel biodegradable poly (glycerol-adipate) nanoparticles in DAOY monolayer.

Journal of controlled release : official journal of the Controlled Release Society·2006

Area of Science:

  • Oncology
  • Immunology
  • Pharmacology

Background:

  • Antibody-drug conjugates (ADCs) have been investigated since 1958.
  • Recent years have seen significant clinical advancements in ADC therapy.
  • Understanding the mechanisms of action of ADCs has driven progress.

Purpose of the Study:

  • To consolidate the foundational principles of ADC development.
  • To review evidence supporting these principles.
  • To assess the effectiveness and selectivity of targeted drug conjugates.

Main Methods:

  • Review of existing literature on antibody-drug conjugates.
  • Analysis of fundamental principles governing ADC function.
  • Examination of clinical trial data (Phase I and II) for effectiveness and selectivity.

Related Experiment Videos

Main Results:

  • The activity of many ADCs can be explained by established principles.
  • Development of ADCs using conventional and potent anti-cancer agents has yielded promising clinical trials.
  • Phase I and II trials show good evidence of effectiveness for ADCs.

Conclusions:

  • ADCs demonstrate significant potential in targeted cancer therapy.
  • The findings suggest ADCs may represent a new era in chemotherapy.
  • Further research and clinical application of ADCs are warranted.